Toxicity and Pharmacokinetics of Cefepime (BMY-28142) Following Intravitreal Injection in Pigmented Rabbit Eyes

Journal of Ocular Pharmacology

Volumn 4, Issue 4, 1988, Pages 345-349

  Jay, Walter M ^a   Shockley, Robert K ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Murex Corporation ^*  (Georgia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; DRUG TISSUE LEVEL; DRUG TOXICITY; ELECTRORETINOGRAPHY; NONHUMAN; RABBIT; RETINA; TOPICAL DRUG ADMINISTRATION; VITREOUS BODY;

ANIMAL; AQUEOUS HUMOR; CEPHALOSPORINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; EYE; INJECTIONS; RABBITS; VITREOUS BODY;

EID: 0024213786     PISSN: 87563320     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.1988.4.345     Document Type: Article

References (14)

1. Barza, M., and Baum, J.: Penetration of ocular compartments by penicillins. Surv. Ophthalmol 18:71–82, 1973.
2. Barza, M.: Factors affecting the intraocular penetration of antibiotics. Scand. J. Infect.Dis. 14 (suppl):151–159, 1978.
3. Peyman, G.A.: Antibiotic administration in the treatment of bacterial endophthalmitis: II. Intravitreal injections. Surv. Ophthalmol. 21:332–346, 1977.
4. Baum, J., Peyman, G.A., and Barza, M.: Intravitreal administration of antibiotic in the treatment of bacterial endophthalmitis. III. Consensus. Surv. Ophthalmol. 26:204–206, 1982.
5. Daily, M.J., Peyman, G.A., and Fishman, G.: Intravitreal injection of methicillin for treatment of endophthalmitis. Am. J. Ophthalmol. 76:343–350, 1973.
6. Forgue, S.T., Shyu, W.C., Gleason, C.R., Pittman, K.A., and Barbhaiya, R.H.,: Pharmacokinetics of the novel cephalosporin cefepime (BMY-28142) in rats and monkeys. Antimicrob. Agents Chemother. 31:799–804, 1987.
7. Cynamon, M.H., Palmer, G.S., and Sorg, T.B.: Comparative in vitro activities of ampicillin BMY-28142, and imipenem against Mycobacterium avium complex. Diaqn. Microbiol. Infect. Dis. 6:151–155, 1987.
8. Marchou, B., Hamzehpour, M.M., Lucain, C., and Pechere, J.C.: Development of B-lactam-resistant Enterobacter cloacae in mice. J. Infect. Diseases 156:369–373, 1987.
9. Barbhaiya, R.H., Forgue, S.T., Shyu, W.C., Papp, E.A., and Pittman, K.A.: High-pressure liquid chemotographic analysis of BMY-28142 in plasma and urine. Antimicrob. Agents Chemother. 31:55–59, 1987.
10. Shockley, R.K., Jay, W.M., Friberg, T.R., et al: Intravitreal ceftriaxone in a rabbit model: Dose - and time-dependent toxic effects and pharmacokinetic analysis. Arch. Ophthalmol., 102:1236–1238, 1984.
11. Edberg, S.C., and Sabath, L.D. Determination of antibiotic levels in body fluids: Techniques and significance: Bactericidal tests in endocarditis and other severe infections. In Antibiotics in Laboratory, Lorian V. (ed). Baltimore, Williams, and Wilkins Co., 1980, pp 206–264.
12. Spivey, B.E., and Pearlman, J.T.: Day-to-day variations in the ERG of humans and rabbits. Am. J. Ophthalmol., 55:1013–1020, 1963.
13. Lawwill, T.: Practical rabbit electroretinography. Am. J. Ophthalmol., 74:135–141, 1972.
14. Norden, C.W., and Neiderriter, K.: In vitro activity of BMY-28142, a new cephalosporin. Chemotherapy 33:15–17, 1987.